Detection of Fluconazole Resistance in Candida parapsilosis Clinical Isolates with MALDI-TOF Analysis: A Proof-of-Concept Preliminary Study
Open Access
- 23 December 2025
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (1) , 9
Abstract
In the context of evolving antifungal resistance and increasing reports of clinical outbreaks of non-albicans Candida spp. invasive infections, the rapid detection of resistant patterns is of the utmost importance. Currently, an azole-resistant Candida parapsilosis clinical outbreak is ongoing at Pisa University Hospital. Resistant isolates bear both Y132F and S862C amino acid substitutions. Based on the data and isolates retrieved during the clinical outbreak, mass spectrometry was used to investigate the differences between fluconazole-resistant and -susceptible clinical strains directly from yeast colonies isolated from agar culture media. A total of 39 isolates, 16 susceptible and 23 resistant, were included. Spectra were processed following a standardized pipeline. Several supervised machine learning classifiers such as Random Forest, Light Gradient Boosting Machine, and Support Vector Machine, with and without principal component analysis were implemented to discriminate resistant from susceptible isolates. Support Vector Machine with principal component analysis showed the highest sensitivity in detecting fluconazole resistance (100%). Despite these promising results, external prospective validation of the algorithm with a higher number of clinical isolates retrieved from multiple clinical centers is required.Keywords
Funding Information
- European Commission (ECS00000017)
- European Commission (CUP I53C22000780001)
This publication has 37 references indexed in Scilit:
- Global incidence and mortality of severe fungal diseaseThe Lancet Infectious Diseases, 2024
- The WHO fungal priority pathogens list as a game-changerNature Reviews Microbiology, 2023
- Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafunginJournal of Antimicrobial Chemotherapy, 2022
- Recent Trends in the Epidemiology of Fungal InfectionsInfectious Disease Clinics of North America, 2021
- Emergence of azole-resistantCandida parapsilosiscausing bloodstream infection: results from laboratory-based sentinel surveillance in South AfricaJournal of Antimicrobial Chemotherapy, 2016
- MALDI-TOF Mass Spectrometry: Any Use for Aspergilli?Mycopathologia, 2014
- MALDI-TOF Mass Spectrometry for Microorganism IdentificationClinics In Laboratory Medicine, 2013
- Unipro UGENE: a unified bioinformatics toolkitBioinformatics, 2012
- MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazoleProteomics, 2009
- MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markersAnalytical and Bioanalytical Chemistry, 2008